pharmaceuticals-and-healthcare

Global Intranasal Drug Delivery Market Insights, Forecast to 2025


Published On : Aug 2018

Category : Pharmaceutical

No. of Pages : 100 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Intranasal Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intranasal Drug Delivery in these regions.
This research report categorizes the global Intranasal Drug Delivery market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The classification of Intranasal Drug Delivery Devices includes Multidose and Uni/bidose, and the proportion of Multidose in 2017 is about 85%, and the proportion is in decreasing trend from 2013 to 2017.

North America, especially The United States, will still play an important role which cannot be ignored, with market size of 340 million USD in 2017 and will be 770 million USD in 2025. Any changes from United States might affect the development trend of Intranasal Drug Delivery Devices. North America region is the largest consumer of Intranasal Drug Delivery Devices, with a market share nearly 43% in 2017.

Europe also plays important roles in global market, with market size of 270 million USD in 2017, enjoying sales market share nearly 34% in 2017.The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
In 2017, the global Intranasal Drug Delivery market size was 780 million US$ and is forecast to 1730 million US in 2025, growing at a CAGR of 10.5% from 2018. The objectives of this study are to define, segment, and project the size of the Intranasal Drug Delivery market based on company, product type, application and key regions.

The various contributors involved in the value chain of Intranasal Drug Delivery include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Intranasal Drug Delivery include
BD
AptarGroup
3M
Teleflex
HT Presspart
Bespak
Pfizer
Novartis
Becton Dickinson
Johnson & Johnson
Merck
GlaxoSmithKline
Nemera
OptiNose
AstraZeneca

Market Size Split by Type
Multidose
Uni/bidose
Market Size Split by Application
Personal Use
Hospital Use

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Intranasal Drug Delivery market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Intranasal Drug Delivery market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intranasal Drug Delivery manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intranasal Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Intranasal Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Intranasal Drug Delivery are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intranasal Drug Delivery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global intranasal drug delivery market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global intranasal drug delivery market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global intranasal drug delivery market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global intranasal drug delivery market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global intranasal drug delivery market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global intranasal drug delivery market insights forecast to 2025, including the definition, classification, and industry chain structure of Global intranasal drug delivery market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global intranasal drug delivery market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global intranasal drug delivery market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global intranasal drug delivery market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global intranasal drug delivery market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global intranasal drug delivery market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global intranasal drug delivery market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Intranasal Drug Delivery
Figure Global Intranasal Drug Delivery Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Intranasal Drug Delivery Production Market Share by Types (Product Category) in 2017
Figure Multidose Product Picture
Table Major Manufacturers of Multidose
Figure Uni/bidose Product Picture
Table Major Manufacturers of Uni/bidose
Table Global Intranasal Drug Delivery Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Personal Use
Figure Hospital Use
Figure Intranasal Drug Delivery Report Years Considered
Figure Global Intranasal Drug Delivery Market Size 2016-2025 (Million US$)
Figure Global Intranasal Drug Delivery Sales 2016-2025 (K Units)
Table Global Intranasal Drug Delivery Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Intranasal Drug Delivery Sales by Regions 2016-2025 (K Units)
Table Global Intranasal Drug Delivery Sales Market Share by Regions 2016-2025
Figure Global Intranasal Drug Delivery Sales Market Share by Regions 2016-2025
Figure 2017 Global Intranasal Drug Delivery Sales Market Share by Regions
Table Global Intranasal Drug Delivery Revenue by Regions 2016-2025 (Million US$)
Table Global Intranasal Drug Delivery Revenue Market Share by Regions 2016-2025
Figure Global Intranasal Drug Delivery Revenue Market Share by Regions 2016-2025
Figure 2017 Global Intranasal Drug Delivery Revenue Market Share by Regions
Table Global Intranasal Drug Delivery Sales by Manufacturers (2016-2018) (K Units)
Table Global Intranasal Drug Delivery Sales Share by Manufacturers (2016-2018)
Figure Global Intranasal Drug Delivery Sales Share by Manufacturers in 2017
Table Intranasal Drug Delivery Revenue by Manufacturers (2016-2018) (Million US$)
Table Intranasal Drug Delivery Revenue Share by Manufacturers (2016-2018)
Figure Intranasal Drug Delivery Value Share by Manufacturers in 2017
Table Global Intranasal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Intranasal Drug Delivery Price (2016-2018) (USD/Unit)
Table Intranasal Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Intranasal Drug Delivery Product Category
Table Date of International Manufacturers Enter into Intranasal Drug Delivery Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Global Intranasal Drug Delivery Sales Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Sales Market Share by Type in 2017
Table Global Intranasal Drug Delivery Revenue by Type (2016-2025) (Million US$)
Table Global Intranasal Drug Delivery Revenue Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Revenue Market Share by Type (2016-2025)
Figure Global Intranasal Drug Delivery Revenue Market Share by Type in 2017
Table Intranasal Drug Delivery Price by Type 2013-2018 (USD/Unit)
Table Global Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Global Intranasal Drug Delivery Sales Share by Application (2016-2025)
Figure Global Sales Intranasal Drug Delivery Market Share by Application (2016-2025)
Figure Global Sales Intranasal Drug Delivery Market Share by Application (2016-2025)
Figure North America Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure North America Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table North America Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Sales Market Share by Countries
Table North America Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table North America Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Revenue Market Share by Countries
Figure United States Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure United States Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Canada Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table North America Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Market Share by Type
Table North America Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 North America Intranasal Drug Delivery Market Share by Application
Table North America Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table North America Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure North America Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Europe Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Europe Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Sales Market Share by Countries
Table Europe Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Europe Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Revenue Market Share by Countries
Figure Germany Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Germany Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (K Units)
Figure France Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure France Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (K Units)
Figure UK Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure UK Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Italy Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Russia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Market Share by Type
Table Europe Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Europe Intranasal Drug Delivery Market Share by Application
Table Europe Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Europe Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Europe Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Asia Pacific Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Sales Market Share by Countries
Table Asia Pacific Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Revenue Market Share by Countries
Figure China Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure China Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Japan Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Korea Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure India Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure India Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Australia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Market Share by Type
Table Asia Pacific Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Intranasal Drug Delivery Market Share by Application
Table Asia Pacific Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Asia Pacific Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Asia Pacific Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Central & South America Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Sales Market Share by Countries
Table Central & South America Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Revenue Market Share by Countries
Figure Brazil Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Market Share by Type
Table Central & South America Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Intranasal Drug Delivery Market Share by Application
Table Central & South America Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Central & South America Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Central & South America Intranasal Drug Delivery Sales Market Share by Company in 2017
Figure Middle East and Africa Intranasal Drug Delivery Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Intranasal Drug Delivery Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Intranasal Drug Delivery Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Sales Market Share by Countries
Table Middle East and Africa Intranasal Drug Delivery Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Intranasal Drug Delivery Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Revenue Market Share by Countries
Figure GCC Countries Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Intranasal Drug Delivery Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Intranasal Drug Delivery Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Intranasal Drug Delivery Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Market Share by Type
Table Middle East and Africa Intranasal Drug Delivery Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Intranasal Drug Delivery Market Share by Application
Table Middle East and Africa Intranasal Drug Delivery Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Intranasal Drug Delivery Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Intranasal Drug Delivery Sales Market Share by Company in 2017
Table BD Company Details
Table BD Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table BD Recent Development
Table AptarGroup Company Details
Table AptarGroup Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AptarGroup Recent Development
Table 3M Company Details
Table 3M Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table 3M Recent Development
Table Teleflex Company Details
Table Teleflex Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teleflex Recent Development
Table HT Presspart Company Details
Table HT Presspart Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table HT Presspart Recent Development
Table Bespak Company Details
Table Bespak Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bespak Recent Development
Table Pfizer Company Details
Table Pfizer Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Becton Dickinson Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Intranasal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table GlaxoSmithKline Company Details
Table Nemera Company Details
Table OptiNose Company Details
Table AstraZeneca Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Intranasal Drug Delivery Value Chain
Table Typical Suppliers of Key Intranasal Drug Delivery Raw Material
Table Intranasal Drug Delivery Customers List
Table Intranasal Drug Delivery Sales Channels
Table Intranasal Drug Delivery Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top